NAP1051, a Lipoxin A4 Biomimetic Analogue, Demonstrates Antitumor Activity Against the Tumor Microenvironment.
Dong T, Dave P, Yoo E, Ebright B, Ahluwalia K, Zhou E, Asante I, Salimova M, Pei H, Lin T, Mead A, Li Z, Humayun M, Petasis NA, Epstein AL, Louie SG.
Dong T, et al. Among authors: asante i.
Mol Cancer Ther. 2021 Dec;20(12):2384-2397. doi: 10.1158/1535-7163.MCT-21-0414. Epub 2021 Oct 4.
Mol Cancer Ther. 2021.
PMID: 34607931